Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

KING SYSTEMS CORPORATION.

US

Last updated September 17, 2026

Information

Country
US
Address
15011 HERRIMAN BLVD., Noblesville, IN, 46060
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
1824226
DUNS Number
—

Catalogue (1113)

Page 16 of 23
DeviceModel / ReferenceRegistriesClassStatus
Universal Flex2®breathing Circuit KNCF370-61Z
FDA UDI
Class IActive
Universal F2®anesthesia Breathing Circuit D390-61Z
FDA UDI
Class IActive
Adult Anesthesiabreathing Circuit 8603F-61Z
FDA UDI
Class IActive
Universal F® Flex2® KNAF376-6121Z
FDA UDI
Class IActive
Universal F2®anesthesia Breathing Circuit NC365-61Z
FDA UDI
Class IUnknown
Adult Ultra Flex®anesthesia Breathing Circuit 8613F-80Z
FDA UDI
Class IActive
Disposable Xenon Kitfor Nuclear Medicine 20035
FDA UDI
Class IIActive
Universal F2®anesthesia Breathing Circuit NC365-06Z
FDA UDI
Class IUnknown
Universal F® Flex2® AF376-176Z
FDA UDI
Class IActive
1 Liter Rainbow Breathing Bag® Y10901
FDA UDI
Class IActive
Breathing Bag 5140
FDA UDI
Class IActive
Adult Anesthesia 8403B-61Z
FDA UDI
Class IActive
Pediatric Ultra Flex®anesthesia Breathing Circuit 2906B-61
FDA UDI
Class IActive
Universal F2®anesthesia Breathing Circuit D390-6121Z
FDA UDI
Class IActive
Pediatric Anesthesia 2600
FDA UDI
Class IActive
Adult Ultra Flex®anesthesia Breathing Circuit KN6753B-06Z
FDA UDI
Class IUnknown
Universal F2®anesthesia Breathing Circuit D465-8021Z
FDA UDI
Class IActive
Custom Accessory D081
FDA UDI
Class IActive
Universal F2®breathing Circuit & Pack Kit F90617
FDA UDI
Class IUnknown
Universal F2®anesthesia Breathing Circuit D460-8021Z
FDA UDI
Class IActive
Universal Flex2®breathing Circuit DF375-6033Z
FDA UDI
Class IUnknown
Universal Flex2®breathing Circuit DF475-176Z
FDA UDI
Class IUnknown
Universal Flex2®breathing Circuit DF470-6021Z
FDA UDI
Class IUnknown
Pediatric Anesthesiabreathing Circuit 2606-61Z
FDA UDI
Class IActive
Jackson Rees 3872-400Z
FDA UDI
Class IActive
Universal Flex2®breathing Circuit NCF375-6121Z
FDA UDI
Class IActive
Disposable Xenon Circuitfor Nuclear Medicine 22116WP
FDA UDI
Class IIActive
Universal F® Flex2® F22001
FDA UDI
Class IActive
Universal Flex2® KNDF370-6121Z
FDA UDI
Class IActive
Pediatric Ultra Flex® 21216Y-16421
FDA UDI
Class IActive
6" Nafion Tubing 7083
FDA UDI
Class IActive
Universal F2®anesthesia Breathing Circuit D460-6021Z
FDA UDI
Class IUnknown
Adult Ultra Flex®anesthesia Circuit & Pack Kit 94360
FDA UDI
Class IUnknown
Universal F® U040-61
FDA UDI
Class IActive
Mapleson C Circuit 5-30843ZL
FDA UDI
Class IActive
Adult Anesthesiabreathing Circuit 90183
FDA UDI
Class IActive
Universal F® X001
FDA UDI
Class IActive
Ped F2® Pediatricanesthesia Breathing Circuit PDP160-6133
FDA UDI
Class IUnknown
Pediatric Anesthesia 2502-61Z
FDA UDI
Class IActive
Adult Anesthesiabreathing Circuit N8603B-61Z
FDA UDI
Class IActive
Jackson Rees 61771P-413
FDA UDI
Class IActive
Pediatric Ultra Flex®anesthesia Breathing Circuit 2906P-13621
FDA UDI
Class IActive
Universal Flex2®breathing Circuit DF376-61Z
FDA UDI
Class IActive
KING LTS-D Kit KLTSD430
FDA UDI
Class IUnknown
Universal F® Flex2® JAF370-6121Z
FDA UDI
Class IActive
Pediatric Anesthesiabreathing Circuit 2606P-6121
FDA UDI
Class IActive
Universal Flex2®breathing Circuit NCF475-61Z
FDA UDI
Class IUnknown
Universal F® Flex2® AF375-6121Z
FDA UDI
Class IActive
Universal F2®anesthesia Breathing Circuit D466-8021Z
FDA UDI
Class IUnknown
Universal F2®anesthesia Breathing Circuit D340-6121Z
FDA UDI
Class IActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (100)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Feb 17, 2015Z-1361-2015—terminated

Product is mislabeled as Double Swivel Connector with Suction Port and is actually Double Swivel Connector without Suction port. If the incorrect component is not identified prior to clinical use, the incorrect connector would be replaced during the case without risk to the patient and could result in a short delay of the procedure.

Sep 3, 2013Z-2255-2013—terminated

Report that size 5 KLTD airways were packaged in pouches indicating a size of 2.5 and shipped to your facility. The correct size of the KLTD airway is clearly marked on the actual airway product and the physical size difference between 2.5 and 5 is distinct and obvious.

Nov 2, 2012Z-0426-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0420-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0421-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0418-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0419-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0425-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0427-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0423-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0424-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0422-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Aug 23, 2012Z-2272-2013—terminated

King Systems received a customer complaint indicating that the customer had ordered a breathing circuit with a Latex breathing bag. The product they received contained a Latex breathing bag, but was labeled as non-latex.

Jan 24, 2011Z-1889-2011—terminated

The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.

Jan 24, 2011Z-1879-2011—terminated

The firms contract manufacturer reported that the products were below the specification for hardness. This could contribute to a higher incidence of problems during the insertion and final positioning of the airway in the patient. In rare instances the softness of the tube could cause the tube to fold over.

Jan 24, 2011Z-1888-2011—terminated

The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.

Jan 24, 2011Z-1890-2011—terminated

The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.

Jan 24, 2011Z-1887-2011—terminated

The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.

Jan 24, 2011Z-1892-2011—terminated

The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.

Jan 24, 2011Z-1878-2011—terminated

The firms contract manufacturer reported that the products were below the specification for hardness. This could contribute to a higher incidence of problems during the insertion and final positioning of the airway in the patient. In rare instances the softness of the tube could cause the tube to fold over.

Jan 24, 2011Z-1891-2011—terminated

The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.

Jan 14, 2011Z-1718-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1706-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1714-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1720-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1721-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1707-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1710-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1717-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1713-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1712-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1705-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1708-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1715-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1709-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1719-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1716-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1711-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Dec 15, 2009Z-0978-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0986-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0975-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0980-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0976-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0982-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0984-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0985-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0983-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0974-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0977-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0981-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0979-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Aug 1, 2008Z-0789-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0745-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0795-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0809-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0730-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0794-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0721-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0757-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0691-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0701-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0804-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0813-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0685-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0687-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0729-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0734-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0758-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0807-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0696-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0699-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0783-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0816-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0709-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0700-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0714-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0689-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0805-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0812-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0742-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0748-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0796-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0782-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0790-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0736-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0800-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0724-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0683-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0761-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0814-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0682-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0679-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0764-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0681-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0773-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0722-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0740-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0752-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0772-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0785-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.